Kim Kardashian Forced to Post ‘Corrective Ad’ After Morning Sickness Drug Debacle
Social media is good for a lot of thing, but maybe not for pimping out medication.
Kim Kardashian has been forced to post a “corrective ad” after the U.S. Food and Drug Administration found that her last attempt at promoting Diclegis, a morning sickness pill made by a small drug company called Duchesnay, lacked the necessary information that must be disclosed to the public like, say, the drug’s potentially dangerous side effects.
The initial posting was first shared on Kardashian’s Instagram on July 19. At the end of August, the FDA sent a warning letter to Duchesnay claiming that the ad was “false and misleading” because it didn’t include warnings about side effects. The ad in question also didn’t explicitly say that it was a promotional piece, despite the fact that the 34-year-old was clearly trying to hawk out some medicine.
To right her wrongs, the 34-year-old shared a correction ad about the drug on Sunday. The full endorsement read:
#CorrectiveAd I guess you saw the attention my last #morningsickness post received. The FDA has told Duchesnay, Inc., that my last post about Diclegis (doxylamine succinate and pyridoxine HCl) was incomplete because it did not include any risk information or important limitations of use for Diclegis. A link to this information accompanied the post, but this didn’t meet FDA requirements. So, I’m re-posting and sharing this important information about Diclegis. For US Residents Only. Diclegis is a prescription medicine used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments. Limitation of Use: Diclegis has not been studied in women with hyperemesis gravidarum. Important Safety Information Do not take Diclegis if you are allergic to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any of the ingredients in Diclegis. You should also not take Diclegis in combination with medicines called monoamine oxidase inhibitors (MAOIs), as these medicines can intensify and prolong the adverse CNS effects of Diclegis. The most common side effect of Diclegis is drowsiness. Do not drive, operate heavy machinery, or other activities that need your full attention unless your healthcare provider says that you may do so. Do not drink alcohol, or take other central nervous system depressants such as cough and cold medicines, certain pain medicines, and medicines that help you sleep while you take Diclegis. Severe drowsiness can happen or become worse causing falls or accidents. Tell your healthcare provider about all of your medical conditions, including if you are breastfeeding or plan to breastfeed. Diclegis can pass into your breast milk and may harm your baby. You should not breastfeed while using Diclegis. Additional safety information can be found at www.DiclegisImportantSafetyinfo.com or www.Diclegis.com. Duchesnay USA encourages you to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.